EGFR mutations are more frequent in well-differentiated than in poor-differentiated lung adenocarcinomas

Pathology and Oncology Research

Volumn 14, Issue 4, 2008, Pages 373-379

  Liu, Yan ^a,b   Xu, Mei Lin ^b   Zhong, Hao Hao ^a   Heng, Wan Jie ^a   Wu, Bing Quan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b TIANJIN CHEST HOSPITAL   (China)

Author keywords

Chemotherapy; Epidermal growth factor receptor; Lung adenocarcinoma; Polymerase chain reaction; Sequence analysis

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; NAVELBINE;

AGED; AMINO ACID SUBSTITUTION; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CODON; DISEASE FREE SURVIVAL; DRUG WITHDRAWAL; EXON; FEMALE; GENE DELETION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIPLE CYCLE TREATMENT; MUTATION RATE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PROGNOSIS; SOMATIC MUTATION; THROMBOCYTOPENIA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 60049085120     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9113-1     Document Type: Article

References (22)

1. Paez JG, Janne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497-1500
2. Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med 350:2129-2139
3. Mitsudomi T, Kosaka T, Endoh H et al (2005) Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol 23:2513-2520
4. Qin BM, Chen X, Zhu JD et al (2005) Identification of EGFR kinase domain mutations among lung cancer patients in China: implication of targeted cancer therapy. Cell Res 15:212-217
5. Yang SH, Mechanic LE, Yang P et al (2005) Mutations in tyrosine kinase domain of the epidermal growth factor receptor in non- small-cell lung cancer. Clin Cancer Res 11:2106-2110
6. Rosell R, Ichinose Y, Taron M et al (2005) Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small cell lung cancer. Lung Cancer 50:25-33
7. Sonobe M, Manabe T, Wada H et al (2005) Mutations in the EGFR gene are linked to smoking-independent, lung adenocarcinoma. Br J Cancer 93(3):355-363
8. Heneda H, Sasaki H, Shimizu S et al (2006) Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Lung Cancer 52:47-52
9. Chan SK, Gullick WJ, Hill ME (2006) Mutations of the epidermal growth factor receptor in non-small cell lung cancer - search and destroy. Eup J Cancer 42:17-23
10. Bardelli A, Parsons DW, Sillima N et al (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300:949-57
11. Tokumo M, Toyooka S, Kiura K et al (2005) The relationship between epidermal growth factor receptor mutations and clinico- pathologic features in non-small cell lung cancers. Clin Cancer Res 11:1167-1173
12. Kim KS, Jeong JY, Kim YC et al (2005) Predictors of the response to gefitinib in refractory non-small cell lung cancer. Clin Cancer Res 11:2244-2251
13. Jackman DM, Yeap BY, Sequist LV et al (2006) Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlobinib. Clin Cancer Res 12:3908-3914
14. Pan ZK, Zhang L, Zhang X et al (2005) Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer. Chinese Journal of Cancer 24:919-923
15. Zhou CC, Zhao YM, Tang L et al (2005) Epidermal growth factor receptor mutations in Chinese patients with non-small cell lung cancer. Tumor 25:458-461
16. Jiang B, Zhu GS, Liu F et al (2005) Mutational analysis of EGFR in Chinese patients with NSCLC. Academic Journal of Shanghai Second Medical University 25:1148-1150
17. Yoshida Y, Shibata T, Kokubu A et al (2005) Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 50:1-8
18. Marchetti A, Martella C, Felicioni L et al (2005) EGFR mutations in non-small cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnositic screening with potential implications on pharmacologic treatment. J Clin Oncol 23:857-865
19. Miller VA, Kris MG, Shah N et al (2004) Bronchoioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small cell lung cancer. J Clin Oncol 22:1103-1109
20. Haneda H, Sasaki H, Shimizu S et al (2006) Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Lung Cancer 52:47-52
21. Scagliotti GV, Fossati R, Torri V et al (2003) Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIA non-small-cell lung cancer. J Natl Cancer Inst 95:1453-1461
22. George S, Schell MJ, Detterbeck FC et al (1998) Adjuvant chemotherapy for resected non-small cell carcinoma of the lung: why we still don't know. Oncologist 3:35-44